Date published: 2025-10-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

MEF-2C Activators

MEF-2C, or myocyte enhancer factor 2C, belongs to the MEF-2 family of transcription factors, which play crucial roles in regulating gene expression programs involved in various cellular processes, including differentiation, proliferation, and survival. Specifically, MEF-2C is predominantly expressed in cardiac and skeletal muscle tissues, where it serves as a master regulator of muscle development and function. Functionally, MEF-2C orchestrates the expression of genes involved in muscle differentiation, contractility, and metabolism, thereby contributing to the formation and maintenance of muscle tissue. Additionally, MEF-2C has been implicated in neuronal development and synaptic plasticity, underscoring its diverse roles beyond muscle biology.

Activation of MEF-2C involves complex regulatory mechanisms that integrate diverse signaling pathways and cellular cues. One major mechanism of MEF-2C activation involves its phosphorylation by various kinases, including calcium/calmodulin-dependent protein kinases (CaMKs), mitogen-activated protein kinases (MAPKs), and protein kinase D (PKD). Phosphorylation of MEF-2C promotes its nuclear translocation and transcriptional activity by modulating its DNA-binding affinity and interaction with co-regulatory proteins. Furthermore, MEF-2C activity can be regulated by post-translational modifications such as acetylation, methylation, and sumoylation, which influence its stability, subcellular localization, and interactions with other proteins. Additionally, MEF-2C activity can be modulated by signaling pathways activated by extracellular cues, including growth factors, hormones, and mechanical stimuli, which converge on intracellular signaling cascades that ultimately regulate MEF-2C transcriptional activity. Overall, the activation of MEF-2C is a tightly regulated process essential for coordinating gene expression programs critical for muscle development, function, and adaptation to environmental stimuli.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

SB431542 is a selective inhibitor of the TGF-β receptor ALK5, blocking TGF-β signaling. By inhibiting ALK5, SB431542 disrupts the TGF-β pathway, potentially influencing MEF-2C activation.

XMD 8-92 (free base)

1234480-50-2sc-364068
sc-364068A
sc-364068B
sc-364068C
5 mg
10 mg
100 mg
1 g
$235.00
$340.00
$1700.00
$10330.00
10
(0)

XMD8-92 is a selective inhibitor of the myocyte enhancer factor 2 (MEF2) family of transcription factors. It disrupts MEF2-DNA binding, potentially influencing MEF-2C activity.

KN-93

139298-40-1sc-202199
1 mg
$178.00
25
(1)

KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII), a kinase implicated in MEF-2C regulation. By inhibiting CaMKII, KN-93 disrupts the downstream signaling events, potentially influencing MEF-2C activation.

AICAR

2627-69-2sc-200659
sc-200659A
sc-200659B
50 mg
250 mg
1 g
$60.00
$270.00
$350.00
48
(2)

AICAR is an activator of AMP-activated protein kinase (AMPK). By activating AMPK, AICAR influences cellular energy homeostasis and potentially modulates MEF-2C activity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059 is a specific inhibitor of MEK1, a component of the MAPK/ERK signaling pathway. MEF-2C activity is influenced by the MAPK/ERK pathway. PD98059 disrupts this pathway, potentially modulating MEF-2C activation.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$99.00
$335.00
$836.00
$2099.00
47
(3)

DAPT is a selective inhibitor of γ-secretase, a protease involved in Notch signaling. MEF-2C is known to interact with the Notch pathway. By inhibiting γ-secretase, DAPT influences MEF-2C activation through modulation of Notch signaling.

GSK-3 Inhibitor IX

667463-62-9sc-202634
sc-202634A
sc-202634B
1 mg
10 mg
50 mg
$57.00
$184.00
$867.00
10
(1)

BIO is a selective glycogen synthase kinase-3 (GSK-3) inhibitor. MEF-2C is known to be regulated by GSK-3. By inhibiting GSK-3, BIO influences downstream signaling events, potentially modulating MEF-2C activation.

GSK-3 Inhibitor XVI

252917-06-9sc-221691
sc-221691A
5 mg
25 mg
$153.00
$520.00
4
(1)

CHIR99021 is a selective inhibitor of glycogen synthase kinase-3 (GSK-3). MEF-2C is known to be regulated by GSK-3. By inhibiting GSK-3, CHIR99021 influences downstream signaling events, potentially modulating MEF-2C activation.